Terminal Sterilization Market size was over USD 13.06 billion in 2024 and is projected to reach USD 47.27 billion by 2037, witnessing around 10.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of terminal sterilization is assessed at USD 14.15 billion. The market is flourishing as a result of the rising burden of HIV across the globe. One of the most significant health and development issues facing the globe today is HIV, which could potentially lead to greater demand for terminal sterilization methods to ensure the sterility of medical equipment. For instance, in 2022, there were more than 35 million HIV-positive individuals in the world.
In addition to these, factors that are believed to boost the business growth of terminal sterilization market include growing innovation in the sterilization process. For instance, in February 2024, to encourage manufacturers' use of low-temperature vaporized hydrogen peroxide, and improve sterilization process innovation, the FDA recognized several consensus standards on sterilization techniques.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.4% |
|
Base Year Market Size (2024) |
USD 13.06 billion |
|
Forecast Year Market Size (2037) |
USD 47.27 billion |
|
Regional Scope |
|
Sterilization Type (Ethylene Oxide, Irradiation, Moist Heat Sterilization, Vaporized Hydrogen Peroxide)
The ethylene oxide segment in the terminal sterilization market is estimated to gain a revenue share of about 42% by the year 2037. The increasing necessity for sterilization due to contamination of medical equipment has contributed to the segment's rise. The smallest molecule in the oxirane family is ethylene oxide which manifests as a transparent, colorless gas with a faint, ethereal smell and is mostly employed in the synthesis of other compounds and is also utilized as a sterilizer.
Healthcare facilities utilize ethylene oxide for the terminal sterilization of important goods that are heat- or moisture-sensitive and cannot be steam-sterilized, and this procedure is known to be extremely regulated, safe, and essential for avoiding infections and guaranteeing that patients receive safe procedures and medical care. Products can be sterilized and made completely germ-free with the use of ethylene oxide, or ETO which uses a mix of vacuum, humidity, temperature, and gas.
Moreover, ethylene oxide terminal sterilization is one of the procedures that are most commonly employed in the medical device sector to eliminate living germs from products that are present in many common healthcare items, including curtains and gowns, as well as implantable medical devices, such as heart valves, bare metal stents, and vascular closure devices, as well as items utilized during implantation operations, such as catheters and guidewires.
Additionally, the process of steam sterilization, which uses moist heat to sterilize objects, is quick, easy, and affordable and coagulates and denaturates structural proteins and enzymes, destroying bacteria irreversibly.
Besides this, one well-known technique for sterilizing pharmaceutical items is irradiation which is an economical and safe way to sterilize single-use medical supplies such as surgical gloves and syringes. For instance, nowadays, radiation sterilization is used in the production of more than 45% of disposable medical devices made in wealthy nations.
End-users (Hospitals, Pharmaceutical Companies, Biopharmaceutical Companies, Medical Device Companies, Diagnostic Labs, Other Manufacturing Sectors, Academic Research Institutes)
The hospitals segment in the terminal sterilization market is set to garner a notable share shortly. The growth of the segment can be credited to the growing risk of hospital-acquired infection. Healthcare-associated infections (HAI), sometimes referred to as hospital-acquired infections (HAI), brought on by bacterial, fungal, and viral pathogens; bloodstream infections (BSI), pneumonia, urinary tract infections (UTI), and surgical site infections (SSI) are the most prevalent forms that typically occur 48 hours following hospital admission. This has fueled the demand for terminal sterilization to prevent the transmission of infectious agents among patients and healthcare providers.
Our in-depth analysis of the terminal sterilization market includes the following segments:
|
Sterilization Type |
|
|
Technology |
|
|
End-User |
|
North American Market Forecast
The terminal sterilization market in North America is slated to hold a share of about 40% by the end of 2037. The sector growth in the region is driven by the growing spending in healthcare. The expense of healthcare is currently rising in the United States, and the nation will likely spend more than USD 6 trillion on healthcare by 2028, making up over 15% of the country's GDP. Particularly, in 2022, US healthcare spending increased by around 4%. As a result, there might be an increasing establishment of healthcare facilities, leading to a greater need for terminal sterilization in the region.
APAC Market Analysis
The Asia Pacific region will also encounter substantial growth for the terminal sterilization market during the forecast period and will hold the second position led by the rising rate of medical tourism. India is home to several super specialty hospitals and is more affordable than other countries as a result the country has seen a sharp increase in medical tourism in recent years.
Moreover, India's medical tourism sector has grown significantly, and the country is striving to become the world's top destination for medical tourism. For instance, India is a well-liked medical tourism destination, drawing over a million patients from more than 75 different countries each year.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?